APP-KI mice are expected to mimic human AD pathology more precisely because: (i) data variation caused by drift of transgene copy number will be eliminated, thus data will be more reliable; and (ii) APP-KI mice have less artificial effects caused by the overexpression of non-Aβ APP fragments which occur in transgenic models. The gene discussed is APP; the disease is Alzheimer disease.